miR-125b |
Mcl-1 |
Inhibition of apoptosis |
Ovarian adenocarcinoma |
[13] |
miR-193a-3p |
Cell proliferation |
Gastric adenocarcinoma |
[14] |
miR-193b-3p |
ETS1 |
Cell proliferation and migration |
Gastric adenocarcinoma |
[15] |
miR-139-5p |
PRKAA1 |
Glycolytic phenotype |
Gastric adenocarcinoma |
[19] |
Notch1 |
Cell proliferation, cell invasion and migration |
Colorectal carcinoma |
[16] |
miR-193a |
CDK9 |
Cell cycle progression, cell proliferation, and inhibition of apoptosis |
Acute monocytic leukemia, acute promyelocytic leukemia |
[21] |
miR-612 |
Akt2 |
Tumor growth, cell invasion, and inhibition of apoptosis |
Glioblastoma |
[23] |
miR-138 |
HIF-1α |
Cell invasion and migration |
Gallbladder carcinoma |
[18] |
miR-216b-5p |
HOXA1 |
Cell proliferation |
Cervix epidermoid carcinoma |
[17] |
miR-153-3p |
Fyn |
Cell proliferation and inhibition of apoptosis |
Esophageal squamous cell carcinoma |
[24] |
miR-1182 |
CDK14 |
Cell proliferation and migration |
Osteosarcoma |
[20] |